Literature DB >> 15673769

Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.

Tadayoshi Ikebe1, Kyoko Hirasawa, Rieko Suzuki, Junko Isobe, Daisuke Tanaka, Chihiro Katsukawa, Ryuji Kawahara, Masaaki Tomita, Kikuyo Ogata, Miyoko Endoh, Rumi Okuno, Haruo Watanabe.   

Abstract

We assessed antimicrobial susceptibility against 211 Streptococcus pyogenes strains isolated from patients with severe invasive group A streptococcal infections. Overall, 3.8, 1.4, 1.4, and 0.5% of the isolates were resistant to erythromycin, clindamycin, telithromycin, and ciprofloxacin, respectively, and 10.4% had intermediate resistance to ciprofloxacin. All isolates were susceptible to ampicillin and cefotaxime.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15673769      PMCID： PMC547282          DOI： 10.1128/AAC.49.2.788-790.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.

Authors:  J C De Azavedo; R H Yeung; D J Bast; C L Duncan; S B Borgia; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

2.  Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin.

Authors:  M Arvand; M Hoeck; H Hahn; J Wagner
Journal:  J Antimicrob Chemother       Date:  2000-10       Impact factor: 5.790

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Serotyping of Streptococcus pyogenes isolated from common and severe invasive infections in Japan, 1990-5: implication of the T3 serotype strain-expansion in TSLS. The Working Group for Group A Streptococci in Japan.

Authors:  Y Inagaki; T Konda; S Murayama; S Yamai; A Matsushima; Y Gyobu; D Tanaka; A Tamaru; C Katsukawa; A Katayama; M Tomita; Y Fuchi; K Hoashi; H Watanabe
Journal:  Epidemiol Infect       Date:  1997-08       Impact factor: 2.451

5.  Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan.

Authors:  Tadayoshi Ikebe; Akihito Wada; Yoshishige Inagaki; Kumiko Sugama; Rieko Suzuki; Daisuke Tanaka; Aki Tamaru; Yoshihiro Fujinaga; Yoshiaki Abe; Yoshikata Shimizu; Haruo Watanabe
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

7.  Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance.

Authors:  S S Yan; M L Fox; S M Holland; F Stock; V J Gill; D P Fedorko
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).

Authors:  D Felmingham; D J Farrell; R R Reinert; I Morrissey
Journal:  J Infect       Date:  2004-01       Impact factor: 6.072

9.  The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

Authors:  D L Stevens; A E Gibbons; R Bergstrom; V Winn
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

10.  Changing prevalent T serotypes and emm genotypes of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan.

Authors:  T Ikebe; N Murai; M Endo; R Okuno; S Murayama; K Saitoh; S Yamai; R Suzuki; J Isobe; D Tanaka; C Katsukawa; A Tamaru; A Katayama; Y Fujinaga; K Hoashi; J Ishikawa; H Watanabe
Journal:  Epidemiol Infect       Date:  2003-06       Impact factor: 2.451
  10 in total
  13 in total

1.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

2.  Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates.

Authors:  M Montes; C Ardanuy; E Tamayo; A Domènech; J Liñares; E Pérez-Trallero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-15       Impact factor: 3.267

3.  Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine.

Authors:  Andrea Fritzer; Beatrice M Senn; Duc Bui Minh; Markus Hanner; Dieter Gelbmann; Birgit Noiges; Tamás Henics; Kai Schulze; Carlos A Guzman; John Goodacre; Alexander von Gabain; Eszter Nagy; Andreas L Meinke
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

4.  Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates.

Authors:  Tadayoshi Ikebe; Manabu Ato; Takayuki Matsumura; Hideki Hasegawa; Tetsutaro Sata; Kazuo Kobayashi; Haruo Watanabe
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

5.  Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes.

Authors:  Masaaki Minami; Takuya Kamimura; Masanori Isaka; Ichiro Tatsuno; Michio Ohta; Tadao Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

6.  Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.

Authors:  Milagrosa Montes; Esther Tamayo; Beatriz Orden; Julián Larruskain; Emilio Perez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

Review 7.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

8.  Characterization of Streptococcus pyogenes isolated from balanoposthitis patients presumably transmitted by penile-oral sexual intercourse.

Authors:  Masaaki Minami; Yukio Wakimoto; Masakado Matsumoto; Hideyuki Matsui; Yasue Kubota; Atsushi Okada; Masanori Isaka; Ichiro Tatsuno; Yasuhito Tanaka; Tadao Hasegawa
Journal:  Curr Microbiol       Date:  2010-01-28       Impact factor: 2.188

9.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

10.  Antibiotic susceptibility of streptococcus pyogenes isolated from respiratory tract infections in dakar, senegal.

Authors:  Makhtar Camara; Assane Dieng; Cheikh Saad Bouh Boye
Journal:  Microbiol Insights       Date:  2013-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.